Your browser doesn't support javascript.
loading
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone.
Leucht, Stefan; Dombi, Zsófia Borbála; Szabó, Péter; Barabássy, Ágota; Levine, Stephen Z.
Affiliation
  • Leucht S; Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum rechts der Isar, Technische Universität München, München, Germany.
  • Dombi ZB; Medical Division, Gedeon Richter Plc., Budapest, Hungary. Electronic address: dombizsb@richter.hu.
  • Szabó P; Medical Division, Gedeon Richter Plc., Budapest, Hungary.
  • Barabássy Á; Medical Division, Gedeon Richter Plc., Budapest, Hungary.
  • Levine SZ; School of Public Health, University of Haifa, Israel.
Schizophr Res ; 261: 24-30, 2023 11.
Article in En | MEDLINE | ID: mdl-37688910
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Risperidone Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Schizophr Res Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Risperidone Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Schizophr Res Year: 2023 Document type: Article